Pediatrix Medical Group, Inc. (MD)
NYSE:MD
Want to see MD full AI Analyst Report?
Earnings Data
Report Date
Jul 30, 2026Before Open (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
0.59Last Year’s EPS
0.53Same Quarter Last Year
Moderate Buy
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presented a majority of positive operational and financial signals: strong Q1 adjusted EBITDA ($58M), above-expectation pricing growth (4%), improved collections (DSO down >5 days YoY), a solid cash balance, modest leverage (~1.3x), successful share repurchase, and strategic senior hires and partner-program rollout. Offsetting items include modest volume declines (NICU days down ~1%), rising clinical salary costs (+$9M S,W,B), higher Q1 cash usage ($130M vs $116M), and uncertainty around the sustainability of RCM-driven pricing and potential effects from tax subsidy lapses. Overall, positives materially outweigh the negatives, though management flagged areas to monitor (pricing tailwind fade, hospital pressures, and executive transition).Company Guidance
Strong Adjusted EBITDA and Reaffirmed Guidance
Q1 adjusted EBITDA of $58 million; management reaffirmed full-year adjusted EBITDA outlook of $280 million to $300 million (midpoint $290 million). Q1 represented roughly 20% of the annual midpoint.
Top-Line Growth Driven by Pricing and Same-Unit Growth
Consolidated revenue growth driven by same-unit growth just under 3% and ~$6 million of net non-same-unit activity (acquisitions and organic growth). Pricing grew ~4% in the quarter, driven by improved RCM cash collections, contract administrative fees, favorable payer mix, and higher neonatology acuity.
Improved Receivables and Cash Position
Accounts receivable DSO improved to 42.5 days (down over five days year over year). Ended the quarter with just over $200 million cash and net debt just over $385 million, reflecting net leverage of just over 1.3x using the midpoint of 2026 adjusted EBITDA guidance.
Successful Capital Deployment and Share Repurchase
Deployed $21 million of capital in the quarter to repurchase 1 million shares, leaving 82 million shares outstanding; recent small acquisitions have performed better than initial projections.
Operational Discipline on Interest Expense and Nonoperating Costs
Other nonoperating expense decreased year over year, driven by lower interest expense from modestly lower average borrowings and slightly lower rates.
Strategic Quality and Leadership Investments
Announced two senior hires in quality: Dr. Jim Barry (Chief Clinical Quality and Transformation Officer) and Dr. Jochen Proffitt (Chief Quality Advisor). Rolled out share price–based awards and welcomed 45 clinician leaders to the inaugural Pediatrix partners class to enhance alignment and retention.
Opportunities to Expand Core and Emerging Services
Management highlighted expansion opportunities across neonatology, maternal-fetal medicine, OB hospitalist, pediatric intensive care, teleservices, and obstetrics leveraging the company’s footprint, data, and remote capabilities.
MD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
MD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 05, 2026 | $22.41 | $20.83 | -7.05% |
Feb 19, 2026 | $21.97 | $19.30 | -12.15% |
Sep 30, 2025 | $16.22 | $16.75 | +3.27% |
Jun 30, 2025 | $14.03 | $14.35 | +2.28% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Pediatrix Medical Group, Inc. (MD) report earnings?
Pediatrix Medical Group, Inc. (MD) is schdueled to report earning on Jul 30, 2026, Before Open (Confirmed).
What is Pediatrix Medical Group, Inc. (MD) earnings time?
Pediatrix Medical Group, Inc. (MD) earnings time is at Jul 30, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MD EPS forecast?
MD EPS forecast for the fiscal quarter 2026 (Q2) is 0.59.